Literature DB >> 25652229

Iron-dependent turnover of IRP-1/c-aconitase in kidney cells.

Ying Liu1, Douglas M Templeton.   

Abstract

The kidney plays an important role in iron homeostasis and actively reabsorbs citrate. The bifunctional iron-regulatory protein IRP-1 potentially regulates iron trafficking and participates in citrate metabolism as a cytosolic (c-) aconitase. We investigated the role of cellular iron status in determining the expression and dynamics of IRP-1 in two renal cell types, with the aim of identifying a role of the protein in cellular ROS levels, citrate metabolism and glutamate production. The effects of iron supplementation and chelation on IRP-1 protein and mRNA levels and protein turnover were compared in cultured primary rat mesangial cells and a porcine renal tubule cell line (LLC-PK1). Levels of ROS were measured in both cell types, and c-aconitase activity, glutamate, and glutathione were measured in LLC-PK1 cells, with and without IRP-1 silencing and in glutamine-supplemented or nominally glutamine-free medium. Iron supplementation decreased IRP-1 levels (e.g., approx. 40% in mesangial cells treated with 10 μg ml(-1) iron for 16 h) and increased ubiquitinated IRP-1 levels in both cells types, with iron chelation having the opposite effect. Although iron increased ROS levels (three-fold with 20 μg ml(-1) iron in mesangial cells and more modestly by about 30% with 50 μg ml(-1) in LLC-PK1 cells, both after 24 h), protein degradation was not ROS-dependent. In LLC-PK1 cells, 10 μg ml(-1) iron (24 h) increased both aconitase activity (30%) and secreted glutamate levels (65%). Silencing did not remove the glutamate response to iron but decreased the c-aconitase activity of the residual protein independent of iron loading (37% and 46% of control levels, without and with iron treatment, respectively). However, in glutamine-free medium, glutamate was still increased by iron, even in IRP-1-silenced cells, and did not correspond to c-aconitase. Silencing decreased the amount of ferritin measured in response to iron loading, decreased the affect of iron on total glutathione by 48%, and increased the response of ROS to iron loading by 38%. We conclude that iron increases turnover of IRP-1 in kidney cells, while increasing aconitase activity, suggesting that the apoprotein (aconitase-inactive) form is not exclusively responsible for turnover. Iron increases glutamate levels in tubule epithelial cells, but this appears to be independent of c-aconitase activity or the availability of extracellular glutamine. IRP-1 protein levels are not regulated by ROS, but IRP-1-dependent ferritin expression may decrease ROS and increase total glutathione levels, suggesting that ferritin levels are more important than citrate metabolism in protecting renal cells against iron.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25652229     DOI: 10.1039/c4mt00315b

Source DB:  PubMed          Journal:  Metallomics        ISSN: 1756-5901            Impact factor:   4.526


  3 in total

1.  Dysregulation of the sensory and regulatory pathways controlling cellular iron metabolism in unilateral obstructive nephropathy.

Authors:  James A Votava; Shannon R Reese; Kathryn M Deck; Christopher P Nizzi; Sheila A Anderson; Arjang Djamali; Richard S Eisenstein
Journal:  Am J Physiol Renal Physiol       Date:  2021-11-29

Review 2.  Therapeutic Implications of Ferroptosis in Renal Fibrosis.

Authors:  Yao Zhang; Yanhua Mou; Jianjian Zhang; Chuanjian Suo; Hai Zhou; Min Gu; Zengjun Wang; Ruoyun Tan
Journal:  Front Mol Biosci       Date:  2022-05-17

3.  Iron bioavailability from supplemented formula milk: effect of lactoferrin addition.

Authors:  Sonia Fernández-Menéndez; María L Fernández-Sánchez; Héctor González-Iglesias; Belén Fernández-Colomer; José López-Sastre; Alfredo Sanz-Medel
Journal:  Eur J Nutr       Date:  2016-10-18       Impact factor: 5.614

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.